Welcome to our dedicated page for abrdn Income Credit Strategies Fund SEC filings (Ticker: ACP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Income-focused investors often comb through abrdn Income Credit Strategies Fund’s dense SEC documents to confirm distribution coverage, credit exposure and leverage levels. Finding that data inside an 8-K or tracking when trustees file a Form 4 can be daunting. Stock Titan gathers every disclosure in one place and layers AI-powered summaries so you get abrdn Income Credit Strategies Fund SEC filings explained simply—no more hunting through footnotes.
Need the annual report 10-K simplified to spot portfolio turnover? Looking for a quarterly earnings report 10-Q filing that details non-accrual loans? Our engine highlights the numbers that move net investment income. Receive alerts for abrdn Income Credit Strategies Fund Form 4 insider transactions real-time and review an interactive timeline of 8-K material events explained in plain English.
Use cases:
- Compare distribution coverage ratios with our abrdn Income Credit Strategies Fund earnings report filing analysis.
- Monitor abrdn Income Credit Strategies Fund insider trading Form 4 transactions before dividend announcements.
- Track executive stock transactions Form 4 in a single click.
- Review the proxy statement executive compensation section to gauge alignment with portfolio performance.
All filings arrive from EDGAR within minutes, tagged by form type and supported by commentary from credit-market specialists. You’ll also find historical PDFs, XBRL data and key exhibits, letting professionals export what they need for models or compliance checks. Understanding abrdn Income Credit Strategies Fund SEC documents with AI means less time parsing schedules and more time making informed decisions.
Form 144 filing: An insider has notified the SEC of an intent to sell 1,694 JFrog Ltd. (FROG) common shares through UBS Financial Services on or after 01 Aug 2025. The shares carry an estimated aggregate market value of $71,927 and represent only about 0.0015 % of the 114.57 million shares outstanding, making the transaction immaterial to the company’s capital structure.
The shares were acquired the same day via a cash-settled stock-option exercise. During the prior three months the same seller disposed of 32,891 shares for gross proceeds of roughly $1.39 million, suggesting continued but modest portfolio diversification.
The notice contains no operational or financial updates and is a routine Rule 144 compliance filing. Market impact should remain negligible unless the cadence or magnitude of future insider sales accelerates.
Teva Pharmaceutical Industries Ltd. (TEVA) has filed a Form 144 announcing the possible sale of 52,742 ordinary shares through Citigroup Global Markets on or about 01-Aug-2025. The shares carry an estimated aggregate market value of $799,437 and equal roughly 0.005 % of the 1.15 billion shares outstanding, indicating a very small portion of the company’s float. The seller—an unnamed insider—received the stock on 01-Aug-2022 via a restricted share-unit (RSU) award. No other sales have been reported in the past three months. A Form 144 is a notice, not a guarantee, but signals that the insider may execute the transaction on the NYSE under Rule 144. Given the modest size and compensation-related origin, market impact is expected to be minimal, though insider sales can be perceived as a slight negative sentiment indicator.
UBS Group AG has filed Amendment No. 11 to Schedule 13G for abrdn Income Credit Strategies Fund (NYSE: ACP) covering the fund’s 5.250% Series A Perpetual Preferred Shares (CUSIP 003057205) as of 30 Jun 2025.
- Beneficial ownership: 682,857 shares, equal to 42.68 % of the outstanding preferred class.
- Voting power: Sole 0; Shared 676.
- Dispositive power: Sole 0; Shared 682,857.
- Shares are held by UBS Group AG and wholly-owned units UBS Financial Services Inc. and UBS Securities LLC.
- The filing is made under Rule 13d-1(b); UBS certifies the position is held in the ordinary course of business with no intent to influence control.
No transactions, valuation metrics, or strategic initiatives are disclosed—this is strictly an ownership update highlighting a significant passive institutional stake.